ConductScience.org, home

Paper36780326

Virus Inactivation Based on Optimal Surfactant Reservoir of Mesoporous Silica.

Hirao R and 3 others. ACS Appl Bio Mater, 2023. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Virus Inactivation Based on Optimal Surfactant Reservoir of Mesoporous Silica. Papers, record 36780326. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36780326

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Virus Inactivation Based on Optimal Surfactant Reservoir of Mesoporous Silica.
PubMed
Journal
ACS Appl Bio Mater
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2024-09-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hirao RRie
2Shigetoh KKeisukehttps://orcid.org/0000-0001-7296-5627
3Inagaki SShinjihttps://orcid.org/0000-0003-0405-5511
4Ishida NNobuhirohttps://orcid.org/0000-0002-3783-3693

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Surface-Active AgentsMajor topic
COVID-19Major topic
Humans
Virus Inactivation
SARS-CoV-2
Cetrimonium
Micelles

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128797969Bioactive mesoporous silica nanostructures with anti-microbial and anti-biofilm properties.Int J Pharm2017https://conductscience.org/library/papers/28797969PubMed
237566314Increased Use of Quaternary Ammonium Compounds during the SARS-CoV-2 Pandemic and Beyond: Consideration of Environmental Implications.Environ Sci Technol Lett2020https://conductscience.org/library/papers/37566314PubMed
333034443Antimicrobial Nanomaterials and Coatings: Current Mechanisms and Future Perspectives to Control the Spread of Viruses Including SARS-CoV-2.ACS Nano2020https://conductscience.org/library/papers/33034443PubMed
430300551Encapsulation and Release of Essential Oils in Functional Silica Nanocontainers.Langmuir2018https://conductscience.org/library/papers/30300551PubMed
525050635Facile, one-pot synthesis, and antibacterial activity of mesoporous silica nanoparticles decorated with well-dispersed silver nanoparticles.ACS Appl Mater Interfaces2014https://conductscience.org/library/papers/25050635PubMed
634149298The viability of SARS-CoV-2 on solid surfaces.Curr Opin Colloid Interface Sci2021https://conductscience.org/library/papers/34149298PubMed
734880490The emergence, genomic diversity and global spread of SARS-CoV-2.Nature2021https://conductscience.org/library/papers/34880490PubMed
825319365Antibacterial dental composites with chlorhexidine and mesoporous silica.J Dent Res2014https://conductscience.org/library/papers/25319365PubMed
935500100Self-Healing and Antibacterial Essential Oil-Loaded Mesoporous Silica/Polyacrylate Hybrid Hydrogel for High-Performance Wearable Body-Strain Sensing.ACS Appl Mater Interfaces2022https://conductscience.org/library/papers/35500100PubMed
109880479Antiseptics and disinfectants: activity, action, and resistance.Clin Microbiol Rev1999https://conductscience.org/library/papers/9880479PubMed
1124131516Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells.ACS Appl Mater Interfaces2013https://conductscience.org/library/papers/24131516PubMed
1225655182Bifunctionalized mesoporous silica-supported gold nanoparticles: intrinsic oxidase and peroxidase catalytic activities for antibacterial applications.Adv Mater2015https://conductscience.org/library/papers/25655182PubMed
1323526816Enzyme-coated mesoporous silica nanoparticles as efficient antibacterial agents in vivo.Adv Healthc Mater2013https://conductscience.org/library/papers/23526816PubMed
1434067553Antiviral Activity of Silver, Copper Oxide and Zinc Oxide Nanoparticle Coatings against SARS-CoV-2.Nanomaterials (Basel)2021https://conductscience.org/library/papers/34067553PubMed
1529208293Mesoporous silica-based bioactive glasses for antibiotic-free antibacterial applications.Mater Sci Eng C Mater Biol Appl2018https://conductscience.org/library/papers/29208293PubMed
1632657566A Surface Coating that Rapidly Inactivates SARS-CoV-2.ACS Appl Mater Interfaces2020https://conductscience.org/library/papers/32657566PubMed
1733350025The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.Rev Med Virol2021https://conductscience.org/library/papers/33350025PubMed
1835138100Transparent Anti-SARS-CoV-2 and Antibacterial Silver Oxide Coatings.ACS Appl Mater Interfaces2022https://conductscience.org/library/papers/35138100PubMed
1932412231Are Quaternary Ammonium Compounds, the Workhorse Disinfectants, Effective against Severe Acute Respiratory Syndrome-Coronavirus-2?ACS Infect Dis2020https://conductscience.org/library/papers/32412231PubMed
2028285049Adsorption and release of ampicillin antibiotic from ordered mesoporous silica.J Colloid Interface Sci2017https://conductscience.org/library/papers/28285049PubMed

See all 39 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
38343039Polypropylene-Rendered Antiviral by Three-Dimensionally Surface-Grafted Poly(N-benzyl-4-vinylpyridinium bromide).ACS Appl Mater Interfaces2024https://conductscience.org/library/papers/38343039PubMed
38140133A Novel Handrub Tablet Loaded with Pre- and Post-Biotic Solid Lipid Nanoparticles Combining Virucidal Activity and Maintenance of the Skin Barrier and Microbiome.Pharmaceutics2023https://conductscience.org/library/papers/38140133PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36780326

GET https://conductscience.org/api/papers/v1/36780326/references?page=2